Given that EGFR protein is a client of Hsp90 and is also controlled by the ubiqutination/proteasome system, we hypothesized that CHIP could be involved in the modulation of the EGFR protein level in pancreatic cancer. This evidence concerns the gene EGFR and pancreatic neoplasm.